Research and science
207 active companies that Compdex files under research and science: 151 classified from what the company does (its name, registered activity, website and brief, at 70% confidence or more) and 58 from the SIC code they registered, where Compdex has not read the company yet. A reading beside the SIC code, never instead of it.
Largest active companies
| Company | Read as | Town | Net assets | Accounts to |
|---|---|---|---|---|
| TAURX THERAPEUTICS MANAGEMENT LTD. | Biotechnology researchClassified from what the company does | Aberdeen | £470,273,971 | 30 Jun 2025 |
| GENOME RESEARCH LIMITED | Biotechnology researchClassified from what the company does | Saffron Walden | £273,699,000 | 30 Sep 2025 |
| ASTEX THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | Cambridge | £163,640,229 | 31 Dec 2025 |
| THE JAMES HUTTON INSTITUTE | Engineering and physical sciences researchClassified from what the company does | Invergowrie | £95,899,000 | 31 Mar 2026 |
| PHARMARON BIOLOGICS (UK) LTD | Biotechnology researchClassified from what the company does | Liverpool | £75,742,104 | 31 Dec 2024 |
| IQVIA LABORATORIES DISCOVERY UK LTD | Biotechnology researchClassified from what the company does | Reading | £55,634,000 | 27 Dec 2025 |
| DOMANTIS LIMITED | Biotechnology researchClassified from what the company does | Stevenage | £51,679,000 | 31 Dec 2025 |
| MAXION THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | London | £50,945,391 | 31 Dec 2025 |
| THE FOUNDATION FOR LIVER RESEARCH | Biotechnology researchClassified from what the company does | London | £48,590,060 | 30 Jun 2025 |
| CONSTRUCTIVE BIOLOGY LIMITED | Biotechnology researchClassified from what the company does | London | £47,985,975 | 31 Dec 2025 |
| QUADRAM INSTITUTE BIOSCIENCE | Biotechnology researchClassified from what the company does | Norwich | £40,660,000 | 31 Mar 2026 |
| CHANGAN UK R & D CENTRE LIMITED | Engineering and physical sciences researchClassified from what the company does | Birmingham | £28,102,082 | 31 Dec 2025 |
| YORK BIOANALYTICAL SOLUTIONS LIMITED | Laboratory servicesClassified from what the company does | Upper Poppleton York | £25,154,086 | 31 Dec 2024 |
| READING SCIENTIFIC SERVICES LIMITED | Laboratory servicesClassified from what the company does | Uxbridge | £24,642,000 | 31 Dec 2025 |
| ALCHEMAB THERAPEUTICS LTD | Biotechnology researchClassified from what the company does | London | £23,246,000 | 31 Dec 2025 |
| PREMIER RESEARCH GROUP LIMITED | Clinical research organisationClassified from what the company does | Reading | £21,057,000 | 31 Dec 2025 |
| SITRYX THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | Oxford | £19,029,355 | 31 Dec 2025 |
| HAMMERSMITH MEDICINES RESEARCH LIMITED | Clinical research organisationClassified from what the company does | London | £17,476,627 | 31 Dec 2025 |
| EVOX THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | Oxford | £14,828,168 | 31 Dec 2025 |
| PROTOSTAR GROUP LIMITED | Engineering and physical sciences researchClassified from what the company does | London | £14,642,370 | 31 Dec 2025 |
| THERADEX (EUROPE) LIMITED | Clinical research organisationClassified from what the company does | Redhill | £14,351,957 | 30 Jun 2025 |
| EMMES BIOPHARMA UK LIMITED | Clinical research organisationClassified from what the company does | Milton Keynes | £13,931,667 | 31 Dec 2025 |
| MEDICINES EVALUATION UNIT LIMITED | Clinical research organisationClassified from what the company does | Reading | £12,650,035 | 31 Dec 2025 |
| SATRA | Engineering and physical sciences researchClassified from what the company does | Kettering | £12,070,383 | 31 Dec 2025 |
| LABGENIUS LIMITED | Biotechnology researchClassified from what the company does | London | £12,035,373 | 31 Dec 2025 |
| ASKBIO UK LTD | Biotechnology researchClassified from what the company does | Midlothian | £11,801,943 | 31 Dec 2025 |
| PHOREMOST LIMITED | Biotechnology researchClassified from what the company does | Cambridge | £11,736,843 | 31 Mar 2025 |
| NUCLEOME THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | Oxford | £11,383,770 | 31 Dec 2025 |
| VERISTAT INTERNATIONAL LIMITED | Clinical research organisationClassified from what the company does | London | £10,081,963 | 31 Dec 2024 |
| NEWALR&D LTD | Biotechnology researchClassified from what the company does | London | £10,079,320 | 31 Mar 2025 |
| SOLASTA BIO LIMITED | Biotechnology researchClassified from what the company does | Glasgow | £9,547,381 | 31 Mar 2025 |
| PATHIOS THERAPEUTICS LIMITED | Biotechnology researchClassified from what the company does | Abingdon | £9,508,621 | 31 Dec 2025 |
| PHAGENESIS LIMITED | Biotechnology researchClassified from what the company does | Manchester | £9,050,868 | 31 Dec 2025 |
| VANTAGE BIOSCIENCES LTD | Biotechnology researchClassified from what the company does | London | £8,343,012 | 31 Dec 2025 |
| ACCELLACARE UK LIMITED | Clinical research organisationClassified from what the company does | Reading | £8,315,861 | 31 Dec 2024 |
| PORTAL BIOTECH LIMITED | Biotechnology researchClassified from what the company does | Guildford | £7,976,618 | 31 Mar 2025 |
| NANOSYRINX LTD | Biotechnology researchClassified from what the company does | Coventry | £7,602,388 | 31 Dec 2025 |
| COLORIFIX LIMITED | Biotechnology researchClassified from what the company does | Norwich | £7,524,729 | 31 Dec 2025 |
| LOCATE BIO LIMITED | Biotechnology researchClassified from what the company does | Nottingham | £7,356,198 | 31 Oct 2025 |
| RICHMOND PHARMACOLOGY LIMITED | Clinical research organisationClassified from what the company does | London | £7,064,435 | 31 Dec 2025 |
| RQ BIOTECHNOLOGY LIMITED | Biotechnology researchClassified from what the company does | London | £6,935,129 | 31 Mar 2026 |
| CANSFORD LABORATORIES LIMITED | Laboratory servicesClassified from what the company does | Cardiff | £6,177,263 | 31 Dec 2024 |
| NCIMB LIMITED | Laboratory servicesClassified from what the company does | Aberdeen | £5,950,003 | 31 Jul 2025 |
| BATTELLE UK LIMITED | Laboratory servicesClassified from what the company does | Chelmsford | £5,887,260 | 30 Sep 2025 |
| EUROFINS SELCIA LIMITED | Laboratory servicesClassified from what the company does | Wolverhampton | £5,848,000 | 31 Dec 2025 |
| UK DRI LTD | Biotechnology researchClassified from what the company does | London | £5,624,526 | 31 Mar 2026 |
| DOMAINEX LIMITED | Biotechnology researchClassified from what the company does | Pampisford | £5,602,282 | 31 Dec 2025 |
| VIANAUTIS BIO LIMITED | Biotechnology researchClassified from what the company does | Cambridge | £5,577,907 | 31 Dec 2025 |
| GLOMAR MINERALS LTD | Engineering and physical sciences researchClassified from what the company does | Southampton | £5,476,032 | 31 Dec 2025 |
| CEREVANCE, LTD | Biotechnology researchClassified from what the company does | Cambridge | £5,462,000 | 31 Dec 2024 |
Sectors
How this is read: each sector lists the SIC codes its companies typically register under. A company whose codes name exactly one sector is filed there from its codes, and said to be. Otherwise a language model places it in one sector from its name, its registered activity, its proved website, its accounts and its brief, choosing among the sectors its codes point at, and must quote its evidence from them; the quote is checked before anything is stored. Only readings at 70% confidence or more are listed. A company read neither way yet is filed by its SIC codes only as far as their sectors agree, to a group or a section; catch-all codes are not read at all. Listed 21 Nov 2026.